Plan in Biological Technology

TransTech Services Partners, Inc. Shareholders Approve Plan of Liquidation; Company To Distribute Amounts in Trust

NEW YORK, July 10 /PRNewswire-FirstCall/ -- TransTech Services Partners, Inc.("Company") (OTC Bulletin Board: TTSPU, TTSP, TTSPW) today announced that its stockholders voted at its special meeting held on July 8, 2009 to approve the plan of liquidation of the Company. The board of directors...

Israeli scientists show bacteria can plan ahead

Bacteria can anticipate a future event and prepare for it, according to new research at the Weizmann Institute of Science. In a paper that appeared today in Nature , Prof. Yitzhak Pilpel, doctoral student Amir Mitchell and research associate Dr. Orna Dahan of the Institute's Molecular Genetics De...

TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution

LA JOLLA, Calif., May 29 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that its Board of Directors has determined, after consideration of potential strategic and financing alternatives, that it is in the best interests of the Company and its stockholders to liqui...

University of Maryland Announces Finalists for $75K Business Plan Competition

COLLEGE PARK, Md., April 8 /PRNewswire-USNewswire/ -- The University of Maryland today announces nine finalist teams for the University of Maryland $75K Business Plan Competition. Finalists present their ideas to a panel of new venture experts on May 8, from 1:30 to 4:30 p.m., at the Uni...

Can Obama Plan Tackle Diabetes Crisis? Epinex Test Could Help

IRVINE, Calif., March 10 /PRNewswire/ -- Diabetes will be a huge burden on President Obama's $634 billion plan to expand and improve healthcare coverage. Epinex Diagnostics , a private biomedical company located in Irvine, California, has developed a new diabetes monitoring device that could rel...

Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US

CRANBURY, N.J., March 5 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Alternext US: PTN) reported that its exchange listing compliance plan submitted on January 23, 2009 has been accepted by the NYSE Alternext US LLC (the "Exchange," formerly known as the American Stock Exchange). ...

FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product

- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 - - Live Teleconference Scheduled with Leadership and Scientific Team for March 04, 2009 - BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: ...

ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall

RANCHO CORDOVA, Calif., Feb. 26 /PRNewswire-FirstCall/ -- ThermoGenesis, Corp. (Nasdaq: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today that the FDA has agreed with its plan to remedy the voluntary recall of certain lots of AXP d...

Vasomotor Symptoms? Create an Individual Treatment Plan for Your Patient

Managing the transition from perimenopause to postmenopause MONTVALE, N.J., Dec. 2 /PRNewswire/ -- The increasing frequency and intensity of vasomotor symptoms is a challenge for women experiencing menopause. OBG Management and The Journal of Family Practice have recently published a ...

Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine

ExCeltrix Preliminary Oncology Data Presented for the First Time San Diego, CA (PRWEB) November 17, 2008 -- Dr. Gail Naughton, CEO of Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today addressed atten...

NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing

KUNMING, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in ...

Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography

JERUSALEM and NEEDHAM, Massachusetts, October 30 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SWX: ORIDN) today announced a three-year purchase agreement with Kaiser Foundation Health Plan, Inc., America's largest non-profit health care provider and the largest non-military medical customer...

Oncothyreon announces prioritization plan for development programs

SEATTLE, Sept. 2 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY) (TSX: ONY) (the "Company") today announced a prioritization plan to focus the Company's resources on the clinical development of PX-478 and PX-866 and on process development and manufacturing of Stimuvax(R). Oncothyreon ...

SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery

LONG BEACH, Calif., Aug. 11 /PRNewswire/ -- It's natural to have concerns before undergoing a surgery, but there are steps you can take beforehand that will make things easier. According to Timothy Schwab, MD, chief medical officer at SCAN Health Plan, planning ahead will help whether you're h...

NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide

NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ) announced today that the new Southern Florida stem cell collection center located in Coral Gables, a suburb of Miami, is targeted to open in September. The center is being opened pursuant to an agreement with CelVida LLC. W...

Arcadian Health Plan Addresses Medicare Doctor Payment Cuts

OAKLAND, Calif., June 30 /PRNewswire/ -- As most doctors face the Congressionally mandated 10 percent cut in Medicare payments next week, Arcadian Health Plan, Inc. announced that it will maintain payments to their contracted network physicians at the same level of payment as before the mandat...

EnterPrize Business Plan Competition Announces Final Phase Winners of Cash Awards Totaling $45,000

Participants raised more than $160 million in venture funding over 10-year life of competition PITTSBURGH, June 27 /PRNewswire/ -- The EnterPrize Business Plan Competition honored two of the region's entrepreneurs at Hyde Park Prime Steakhouse on Pittsburgh's North Shor...

Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs

PRINCETON, N.J., May 30 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it is implementing the next step in its ongoing effort to focus its resources on the company's clinical and la...

Vion Pharmaceuticals Files Plan With Nasdaq

NEW HAVEN, Conn., April 15 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq: VION ) today announced that it had filed a plan to achieve and sustain compliance with The Nasdaq Capital Market listing requirements, including the time frame for completion of the plan. Previously, th...

Advanced Life Sciences Announces Plan to Submit NDA for Cethromycin

CHICAGO, April 10 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), today announced that, based on a productive meeting with the U.S. Food and Drug Administration (FDA), the Company plans to submit a New Drug Application (NDA) in the third quarter of 2008 for it...

AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance

GREENVILLE, S.C., March 20 /PRNewswire-FirstCall/ -- On January 7, 2008, Signalife received a deficiency letter from the American Stock Exchange ("AMEX") pursuant to which it advised that Signalife would need to comply with the $6 million stockholders' equity threshold required for continued l...

PPD Announces Plan to Repurchase Shares of its Common Stock

WILMINGTON, N.C., Feb. 20 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced its plans to begin a stock repurchase program whereby up to $350 million of its common stock may be purchased from time to time in the open market. The company made the decision to initiate a share r...

Federal nanotech risk research plan still comes up short

WASHINGTON, DC An improved but still flawed government-wide plan for nanotechnology risk research is the result of a broken system. Federally-funded studies essential to managing possible risks from this cutting-edge technology should be guided by a top-down strategy tied to projected commercial...

MichBio Responds to Governor's Plan to Repeal Tort Reform Laws

ANN ARBOR, Mich., Jan. 30 /PRNewswire-USNewswire/ -- In a letter to Governor Jennifer Granholm today, MichBio Executive Director, Stephen Rapundalo, Ph.D., responded to the Governor's State of the State Address wherein she called for a repeal of current tort laws. MichBio is the statewide asso...

ORNL 'resilience' plan to help Tennessee, Mississippi and South Carolina communities beat disaster

OAK RIDGE, Tenn., Oct. 4, 2007 A new Oak Ridge National Laboratory initiative could help avert disasters in Tennessee, Mississippi and South Carolina and also lead to more information about climate change. The new Community and Regional Resilience Initiative (CARRI) will be implemented in Gulf...

China Biopharma, Inc. Announces New Plan of Operation

HANGZHOU, China, Nov. 20 /PRNewswire-FirstCall/ -- China Biopharma, Inc. (OTC Bulletin Board: CBPC) today announced its new plan of operation to take closer control and to better improve its current operation results. The company also plans to move away from the increasingly competitive and lo...

Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)

- Significant Efforts to Expand Market and Prepare for Zingo Launch Underway - - Nancy Donahue Promoted To Senior Vice President, Marketing and Sales, and James Carr Promoted To Vice President, Marketing - - Additional Manufacturing Capacity ...

Biomira announces plan to change name to Oncothyreon

EDMONTON, Sept. 27 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: BIOM ) (TSX: BRA) (the "Company") today announced that, as part of the Company's previously announced plan to reincorporate in the United States, it intends to change its name to Oncothyreon Inc. The name change will become eff...

Biomira Announces Plan to Reincorporate in the United States

COMPANY TO HOST CONFERENCE CALL AT 10:00AM EDT EDMONTON, BELLEVUE, WASHINGTON, Sept. 12 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: BIOM ) (TSX: BRA) (the "Company") today announced that the Company's Board of Directors has approved a proposal to change its jurisdiction of inc...

ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ) a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that it has received co...

Pharmaxis Closes Share Purchase Plan

SYDNEY, June 29 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL ) today announced it had raised A$7.2 million from its Share Purchase Plan which closed on 24 June 2009. Shareholders of the company were given the opportunity to purchase up to $5,000 worth of shares each at the $2.35 p...

Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

SYDNEY, June 3 /PRNewswire-Asia/ -- Pharmaxis (ASX: PXS, Nasdaq: PXSL ) today announced that it had raised A$47 million through a placement to Australian and international institutions and professional investors. The placement strengthens the company's balance sheet as Pharmaxis moves towar...

China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan

TAIAN CITY, Shandong, China, Feb. 13 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that one of its ...

Varian, Inc. Announces Cost Reduction Plan

PALO ALTO, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced a plan to eliminate approximately 240 regular employee and 80 temporary positions and to close certain facilities. "In the face of continuing uncertainty in the global economic environment...

XTL Biopharmaceuticals Implements Restructuring Plan

VALLEY COTTAGE, N.Y., Dec. 8 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that it is restructuring its operations following the failure of the Bicifadine Phase 2b clinical trial. The company is terminating the employment of 9 employees, represe...

Aware, Inc. Announces Extension of Stock Repurchase Plan

BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, announced today that its Board of Directors has approved an extension to the program originally authorized on August 28, 2007 to repurchase from tim...

The human brain minimizes energy expenditure and integrates gravity in to the action plan

When reaching for an object, the brain prepares neural commands sent to the target muscles to minimize energy expenditure, according to a study published in PLoS Computational Biology by neuroscientists and mathematicians from the INSERM and ENSTA. How the human brain organizes and controls ...

Vasogen Announces Implementation of Strategic Restructuring Plan

MISSISSAUGA, ON, April 14 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS), today announced that it has implemented a strategic restructuring plan to significantly reduce its cash burn rate and focus its efforts on opportunities that the Board and management believe are most like...

Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan

Plan includes refocusing of operations and workforce reduction NEW YORK, April 4, 2008 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals (Nasdaq: KERX ) today announced that it is implementing a strategic restructuring plan to reduce its cash burn rate and re-focus its development effor...

Shire plc: Long Term Incentive Plan

BASINGSTOKE, England and PHILADELPHIA, Pennsylvania, March 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, announces the release on March 25, 2008, of ordinary shares of 5 pence in the capital of Shire plc ("Shares") i...